Palisade Bio Relocates Headquarters
Ticker: PALI · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Sep 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: office-relocation, 8-k
TL;DR
Palisade Bio moved offices on 9/26/25. New address: 1902 Wright Place, Ste 200, Carlsbad, CA 92008.
AI Summary
On September 26, 2025, PALISADE BIO, INC. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 1902 Wright Place, Suite 200, Carlsbad, California, 92008. This move from their previous address at 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009, was effective as of September 26, 2025.
Why It Matters
A change in principal executive offices can signal operational shifts or cost-saving measures for the company.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's physical address, which typically carries low risk.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- September 26, 2025 (date) — Date of earliest event reported
- 1902 Wright Place, Suite 200, Carlsbad, California, 92008 (location) — New Principal Executive Offices
- 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009 (location) — Former Principal Executive Offices
FAQ
What is the new address for PALISADE BIO, INC.'s principal executive offices?
The new address is 1902 Wright Place, Suite 200, Carlsbad, California, 92008.
When was the change of address effective?
The change of address was effective as of September 26, 2025.
What was the previous address of PALISADE BIO, INC.?
The previous address was 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009.
What type of filing is this?
This is a Form 8-K, a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Stats: 545 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-09-26 17:10:37
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-25-015775.txt ( ) — 197KB
- pali-20250926.xsd (EX-101.SCH) — 3KB
- pali-20250926_lab.xml (EX-101.LAB) — 33KB
- pali-20250926_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2025 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer